Fortis Malar Hospitals Ltd
Incorporated in 1992, Fortis Malar Hospital Ltd is in the business of providing health care & medical services[1]
- Market Cap ₹ 87.3 Cr.
- Current Price ₹ 46.6
- High / Low ₹ 91.3 / 44.0
- Stock P/E
- Book Value ₹ 30.5
- Dividend Yield 0.00 %
- ROCE -0.84 %
- ROE -22.2 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -10.4% over past five years.
- Company has a low return on equity of -16.0% over last 3 years.
- Earnings include an other income of Rs.7.06 Cr.
- Working capital days have increased from 135 days to 219 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
95 | 98 | 108 | 118 | 130 | 141 | 149 | 145 | 112 | 69 | 86 | 86 | 74 | |
82 | 86 | 99 | 110 | 123 | 140 | 147 | 147 | 115 | 76 | 83 | 81 | 75 | |
Operating Profit | 13 | 11 | 9 | 8 | 6 | 1 | 2 | -2 | -3 | -6 | 3 | 5 | -1 |
OPM % | 14% | 12% | 8% | 6% | 5% | 1% | 1% | -2% | -2% | -9% | 4% | 5% | -1% |
2 | 46 | 7 | 7 | 7 | 8 | 8 | 10 | 11 | 15 | 7 | 7 | 7 | |
Interest | 1 | -2 | 0 | 1 | 0 | 0 | 0 | 1 | 8 | 7 | 7 | 6 | 5 |
Depreciation | 3 | 2 | 2 | 3 | 3 | 4 | 4 | 4 | 13 | 13 | 13 | 12 | 12 |
Profit before tax | 11 | 56 | 13 | 12 | 10 | 4 | 5 | 2 | -12 | -11 | -8 | -7 | -11 |
Tax % | 28% | 24% | 34% | 34% | 36% | 30% | 41% | 27% | 26% | 30% | 0% | -119% | |
8 | 43 | 9 | 8 | 6 | 3 | 3 | 2 | -9 | -8 | -8 | -16 | -16 | |
EPS in Rs | 4.15 | 23.22 | 4.60 | 4.12 | 3.35 | 1.51 | 1.68 | 0.93 | -4.83 | -4.27 | -4.43 | -8.29 | -8.42 |
Dividend Payout % | 0% | 0% | 11% | 12% | 15% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | -1% |
5 Years: | -10% |
3 Years: | -8% |
TTM: | -16% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -35% |
TTM: | -75% |
Stock Price CAGR | |
---|---|
10 Years: | 6% |
5 Years: | -3% |
3 Years: | -5% |
1 Year: | -5% |
Return on Equity | |
---|---|
10 Years: | -2% |
5 Years: | -10% |
3 Years: | -16% |
Last Year: | -22% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 |
Reserves | 15 | 58 | 66 | 72 | 78 | 80 | 83 | 85 | 76 | 68 | 59 | 43 | 38 |
8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 64 | 57 | 53 | 46 | 42 | |
77 | 13 | 16 | 19 | 32 | 31 | 46 | 45 | 33 | 23 | 27 | 27 | 27 | |
Total Liabilities | 118 | 90 | 101 | 110 | 129 | 129 | 147 | 148 | 191 | 167 | 159 | 136 | 126 |
39 | 17 | 18 | 18 | 24 | 25 | 24 | 22 | 81 | 69 | 58 | 47 | 44 | |
CWIP | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
79 | 72 | 82 | 92 | 104 | 104 | 123 | 126 | 110 | 98 | 101 | 88 | 82 | |
Total Assets | 118 | 90 | 101 | 110 | 129 | 129 | 147 | 148 | 191 | 167 | 159 | 136 | 126 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
11 | -64 | 6 | 4 | 11 | -10 | 10 | -16 | -0 | -1 | 7 | 6 | |
-10 | 72 | -1 | 5 | -22 | 15 | -2 | 6 | 48 | -28 | 8 | 0 | |
-1 | -7 | -1 | 0 | -1 | -1 | 0 | 0 | -12 | -7 | -10 | -13 | |
Net Cash Flow | 0 | 2 | 3 | 9 | -12 | 4 | 8 | -9 | 36 | -36 | 5 | -7 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 14 | 12 | 13 | 13 | 17 | 14 | 15 | 24 | 12 | 11 | 9 | 14 |
Inventory Days | 4 | 13 | 35 | 28 | 22 | 18 | 22 | 42 | 40 | 32 | ||
Days Payable | 153 | 169 | 286 | 173 | 276 | 255 | 323 | 375 | 429 | 584 | ||
Cash Conversion Cycle | 14 | 12 | -136 | -143 | -234 | -130 | -239 | -212 | -289 | -322 | -379 | -539 |
Working Capital Days | -7 | 213 | 189 | 166 | 127 | 150 | 130 | 154 | -38 | 134 | 52 | 219 |
ROCE % | 30% | 17% | 17% | 14% | 12% | 5% | 6% | 3% | -3% | -7% | -1% | -1% |
Documents
Announcements
- Record Date For Payment Of Interim Dividend 10h
- Corporate Action-Board to consider Dividend 10h
- Prior Intimation Under Regulation 29 Of The SEBI (LODR) Regulations, 2015 ('Listing Regulations') Regarding Declaration Of An Interim Dividend For The Year 2024, If Any. 10h
- Record Date 1d
- Corporate Action-Board to consider Dividend 1d
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1][2]
Company is a part of Fortis Group, being subsidiary of Fortis Hospitals Limited and Intermediate Holding Company of Fortis Healthcare Ltd. The Hospital building is owned by a fellow subsidiary, Fortis Health Management Limited. Company has entered into Hospital and Medical Services Agreement
with FHML for rendering of medical and healthcare services at the hospital building